Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin. - Ghelardi F; Raimondi A; Morano F; Randon G; Pannone A; Guaglio M; Mazzoli G; Nasca V; Milione M; Leoncini G; Sabella G; Greco GF; et al. (Clinical colorectal cancer, 2023)